Kerala's Chief Minister has sparked a debate among medical professionals with remarks questioning the necessity of certain angioplasty procedures. This has prompted a call for a more nuanced discussion based on current clinical evidence and research.
Angioplasty, specifically Percutaneous Coronary Intervention (PCI) involving balloon angioplasty and stent placement, has revolutionized cardiovascular care. In cases of acute heart attacks caused by sudden coronary artery blockages, timely angioplasty and stent insertion can restore blood flow, save heart muscle, and improve survival rates. In such emergencies, there is no dispute about the efficacy of stenting, and second opinions are often deemed unnecessary due to the urgency of the situation.
However, the distinction between life-saving stenting and its use as a routine medical procedure is crucial. A coronary angiogram, which reveals the anatomy of the arteries, does not automatically indicate the need for intervention. Decisions regarding intervention should consider the patient's symptoms, blockage severity, its impact on blood flow, the overall coronary disease pattern, and the anticipated benefits of the procedure.
The Chief Minister's comments have raised concerns among doctors in Kerala, who worry that public apprehension over unnecessary procedures might delay essential treatments. Cardiologists emphasize that while public scrutiny is valid, it should not deter timely medical interventions.
ISCHEMIA Trial Insights
The landmark ISCHEMIA trial, published in 2020 in The New England Journal of Medicine, provides significant insights into this issue. The trial involved 5,179 patients across 37 countries with stable coronary artery disease and moderate to severe ischemia. Participants were divided into two groups: one received an initial invasive strategy involving angiography followed by angioplasty or coronary bypass surgery, while the other group was treated conservatively with optimal medical therapy, reserving revascularization for acute events or persistent angina.
After a median follow-up of 3.2 years, the study found no significant difference in composite outcomes such as cardiac arrests, hospitalizations for unstable angina or heart failure, and mortality rates between the two groups. Even after five years, the results remained consistent, suggesting that patients with stable coronary artery disease on optimal medical treatment fare as well as those undergoing stenting or bypass surgery.
In India, the rise in PCI procedures warrants careful scrutiny. annual PCI procedures surged from approximately 1,13,000 in 2008 to over 7,26,000 in 2024, a more than six-fold increase. In contrast, the United States saw a 40% decline in PCI procedures between 2003 and 2016, attributed to advancements in prevention and treatment.
This disparity raises critical questions about the reasons behind the increase in PCI procedures in India. Is it driven by genuine clinical needs, or are factors such as practice patterns, financial incentives, and gaps in knowledge about the efficacy of optimal medical treatment at play?
Optimal medical therapy, grounded in evidence-based guidelines, remains the cornerstone of care for coronary artery disease patients. This includes LDL-cholesterol lowering, appropriate anti-platelet treatment, blood-pressure control, evidence-based diabetes management, and lifestyle modifications. While a coronary stent addresses a specific narrowing, it does not cure the underlying atherosclerosis or eliminate future heart attack risks. Patients must continue preventive treatments to manage the disease elsewhere in the coronary arteries.
The path forward involves neither condemning cardiologists nor accepting every angioplasty recommendation without question. While most doctors aim to act in their patients' best interests, no profession is immune to inappropriate practices. The ultimate measure of healthcare success is not the number of procedures performed but the number of lives saved and whether patients receive the right treatment at the right time and at an affordable cost.
As the debate continues, it is essential for both the medical community and the public to engage in informed discussions based on the latest evidence, ensuring that patient care remains the top priority.
